Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
20 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Biotech Dental Benelux from Gent, company number BE0544516923, closed financial year 2025 with a result of € 792 after tax. For that financial year Biotech Dental Benelux recorded a gross margin of € 175,643 and equity of € 313,198. Compared with financial year 2024, the result moved from € 72,357 to € 792. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 313,198
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 792
▼ 99% vs 2024
Profit after tax over the fiscal year.
€ 52,715
▲ 26% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 251,698.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 179,460
▲ 94% vs 2024
€ 179,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 106
▼ 53% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 235,581
▲ 59% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 60,392
▼ 6% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 152,863 | € 147,236 | € 202,087 | € 175,643 | ▼ 13% |
| Profit after taxes | € 42,156 | € 37,084 | € 72,357 | € 792 | ▼ 99% |
| Equity | € 202,964 | € 240,049 | € 312,406 | € 313,198 | |
| Total debts | € 212,301 | € 262,836 | € 291,730 | € 465,139 | ▲ 59% |
| Cash | € 87,758 | € 48,556 | € 41,993 | € 52,715 | ▲ 26% |
| Retained profit | € 141,464 | € 178,549 | € 250,906 | € 251,698 | |
| Balance sheet total | € 415,265 | € 502,884 | € 604,136 | € 778,336 | ▲ 29% |
| Employees (FTE) | 1 | 1 | 1 | 1 |
Key figures of Biotech Dental Benelux, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Biotech Dental Benelux?
What happened at Biotech Dental Benelux in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 792 (▼ 99% vs 2024). filed late Source: NBB ↗
- Philippe Veran stepped down as director. NBB
- Guy De Vreese stepped down as director. NBB
- Philippe Veran became a director. NBB
- Guy De Vreese became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 42,156 profit in 2022 to € 792 profit in 2025.
Paid € 59,220 in corporate taxes since 2022.
Best year ever: 2024, with € 72,357 profit.
On average € 175,600 of value added per employee in 2025.
Management
The stake of remedent comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Biotech Dental BeneluxThe shares are held by remedent (50%).
Directors
According to the 2025 annual accounts
Philippe Veran
Director
since 2019 · until 2025
Guy De Vreese
Managing director
Also active at: Shane Invest, remedent, LAUSHA, Condor Technologies, Metrics in Balance, Aesthics, DNA Talks, ELEMENTAL +1 more
since 2019 · until 2025
Shareholders
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Zuiderlaan 1-3 box 8
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
All companies at this address →PAEPSEM
€ 788,648 revenue · 2025
DE COLVENAER
€ 126,511 revenue · 2025
remedent same network
€ 62,168 revenue · 2025
Condor Technologies same network
€ 2,092 revenue · 2025
Pexip Belgium
€ 1.4 million gross margin · 2025
+15 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0544.516.923
- VAT number
- BE 0544.516.923
- Registered office
- Zuiderlaan 1-3 bus 8, 9000 Gent
- Names & denominations
- Biotech Dental Benelux
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 16 January 2014
- Peppol
- Not registered
- Activities · NACE
Groothandel in farmaceutische en medische artikelen